Tag: CRISPR therapeutics
November 24, 2019
5 Top NASDAQ Biotech and Pharma Stocks: Fulcrum Climbs 73 Percent
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 19, 2019
CRISPR and Vertex Release Positive Gene-editing Results
This is the first time CRISPR/Cas9 gene-editing technology has been used in human trials to treat genetic diseases. February 25, 2019
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
CRISPR Therapeutics (NASDAQ:CRSP) has announced financial results for its fourth quarter and full year ended December 31, 2018. As quoted...
February 21, 2019
The Rise of CRISPR Technology
CRISPR technology is a rapidly growing component of the genetics industry. Here's what investors need to know about its future...
November 13, 2018
CRISPR Trials to Watch in 2018
CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress. October 11, 2018
CRISPR Therapeutics and Vertex Announce FDA Has Lifted a Clinical Hold
CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Vertex Pharmaceuticals (NASDAQ:VRTX) today announced... September 21, 2018